ConductScience.org, home

Paper36948878

[Study progress of tyrosine kinase inhibitor discontinuation in children with chronic myeloid leukemia].

Zheng FY and 3 others. Zhonghua Xue Ye Xue Za Zhi, 2023. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. [Study progress of tyrosine kinase inhibitor discontinuation in children with chronic myeloid leukemia]. Papers, record 36948878. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36948878

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Study progress of tyrosine kinase inhibitor discontinuation in children with chronic myeloid leukemia].
PubMed
Journal
Zhonghua Xue Ye Xue Za Zhi
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2025-03-06
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zheng FYF Y
2Wang MM
3Zhang LPL P
4Jiang QQ

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tyrosine Kinase InhibitorsMajor topic
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMajor topic
Humans
Child
Protein Kinase Inhibitors
Chronic Disease

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134439257Discontinuation of Imatinib in Children with Chronic Myeloid Leukemia: A Study from the International Registry of Childhood CML.Cancers (Basel)2021https://conductscience.org/library/papers/34439257PubMed
224810322Sustained complete molecular remission after imatinib discontinuation in children with chronic myeloid leukemia.Pediatr Blood Cancer2014https://conductscience.org/library/papers/24810322PubMed
333672937Definition, Epidemiology, Pathophysiology, and Essential Criteria for Diagnosis of Pediatric Chronic Myeloid Leukemia.Cancers (Basel)2021https://conductscience.org/library/papers/33672937PubMed
428095277Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia.J Clin Oncol2017https://conductscience.org/library/papers/28095277PubMed
532072631
Risk of molecular recurrence after tyrosine kinase inhibitor discontinuation in chronic myeloid leukaemia patients: a systematic review of literature with a meta-analysis of studies over the last ten years.
Br J Haematol2020https://conductscience.org/library/papers/32072631PubMed
632087030Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemia.Br J Haematol2020https://conductscience.org/library/papers/32087030PubMed
724106110Imatinib cessation in children and adolescents with chronic myeloid leukemia in chronic phase.Pediatr Blood Cancer2014https://conductscience.org/library/papers/24106110PubMed
830843196Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study.Br J Haematol2019https://conductscience.org/library/papers/30843196PubMed
933022644Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2020https://conductscience.org/library/papers/33022644PubMed
1025160793Treatment-free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia.Br J Haematol2015https://conductscience.org/library/papers/25160793PubMed
1132127639European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.Leukemia2020https://conductscience.org/library/papers/32127639PubMed
1233718985Chronic Myelogenous Leukemia in Childhood.Curr Oncol Rep2021https://conductscience.org/library/papers/33718985PubMed
1328838993Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents.Haematologica2017https://conductscience.org/library/papers/28838993PubMed
1420965785Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial.Lancet Oncol2010https://conductscience.org/library/papers/20965785PubMed
1534439327Treatment-Free Remission in Chronic Myeloid Leukemia: Can We Identify Prognostic Factors?Cancers (Basel)2021https://conductscience.org/library/papers/34439327PubMed
1629459949Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.Ann Intern Med2018https://conductscience.org/library/papers/29459949PubMed
1731688623Discontinuation of Imatinib in a Child With Chronic Myeloid Leukemia.J Pediatr Hematol Oncol2020https://conductscience.org/library/papers/31688623PubMed
1834714411Health-related quality of life in children with chronic myeloid leukemia in the chronic phase.J Cancer Res Clin Oncol2022https://conductscience.org/library/papers/34714411PubMed
1923704092Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study.Blood2013https://conductscience.org/library/papers/23704092PubMed
2035751859Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring.Am J Hematol2022https://conductscience.org/library/papers/35751859PubMed

Download CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36948878

GET https://conductscience.org/api/papers/v1/36948878/authors